Drugs

In a noteworthy endeavor to tackle the issues linked to epilepsy, an important initiative for raising awareness and enhancing epilepsy management was held through a Continuing Medical Education (CME) session. The focus was on “Recent Developments in Epilepsy Awareness,” and […]

Abbott has introduced its latest pneumococcal conjugate vaccine, PneumoShield 14, designed for children aged six weeks and older. This PCV-14 valent vaccine offers extensive coverage by protecting against the greatest number of serotypes compared to the existing PCV-10 and PCV-13

EY Parthenon (EY-P), a prominent strategy consulting entity, along with the Organisation of Pharmaceutical Producers of India (OPPI), published a report titled ‘Viksit Bharat@2047: Elevating India from Global Pharmacy to International Pharma Leader,’ charting the industry’s path towards global prominence.

**CPHI & PMEC India’s Women Leaders’ Forum Highlighting Pharma Leadership Advancement** In November 2024, the CPHI & PMEC India hosted a pioneering Women in Pharma Forum, uniting female leaders to delve into pivotal issues like mentorship, advocacy, and building networks

Dr Reddy’s Laboratories has unveiled toripalimab in India, a novel biological entity in the realm of medicine. This groundbreaking immuno-oncology medication has secured approval from global regulatory bodies such as the US FDA, EMA, MHRA, and others, specifically targeting adults

Orchid Pharma, in collaboration with the Consortium of Accredited Healthcare Organizations (CAHO), is intensifying efforts to combat antimicrobial resistance (AMR) across India. Their joint mission is to arm healthcare practitioners with essential resources, knowledge, and education for effective antimicrobial management.

Biocon Biologics has partnered with Diabetes Africa and St Paul’s Hospital Millennium Medical College in Ethiopia to implement the ‘Embedding Specialist Nurses in Diabetes Care’ initiative. This project has resulted in a scalable approach to enhancing the skills of nursing

A pre-clinical biotech company from Calgary, Marvel Biosciences Corporation, and its fully owned subsidiary Marvel Biotechnology, have shared new findings from their ongoing preclinical research on Rett syndrome. Conducted in partnership with the iBraiN Institute, these revelations offer encouraging pilot

Nine UK universities have been chosen to form the newly established NIHR Maternity Disparities Consortium, devoted to addressing inequalities in maternity care outcomes. This group will conduct research targeting disparities before, during, and after pregnancy. The consortium is also dedicated